These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

723 related items for PubMed ID: 22003066

  • 1. Antibody conjugate therapeutics: challenges and potential.
    Teicher BA, Chari RV.
    Clin Cancer Res; 2011 Oct 15; 17(20):6389-97. PubMed ID: 22003066
    [Abstract] [Full Text] [Related]

  • 2. What Can We Learn about Antibody-Drug Conjugates from the T-DM1 Experience?
    Esteva FJ, Miller KD, Teicher BA.
    Am Soc Clin Oncol Educ Book; 2015 Oct 15; ():e117-25. PubMed ID: 25993162
    [Abstract] [Full Text] [Related]

  • 3. Antibody-drug conjugate targets.
    Teicher BA.
    Curr Cancer Drug Targets; 2009 Dec 15; 9(8):982-1004. PubMed ID: 20025606
    [Abstract] [Full Text] [Related]

  • 4. Antibody drug conjugates.
    Teicher BA.
    Curr Opin Oncol; 2014 Sep 15; 26(5):476-83. PubMed ID: 25024051
    [Abstract] [Full Text] [Related]

  • 5. Targeted cancer therapy: conferring specificity to cytotoxic drugs.
    Chari RV.
    Acc Chem Res; 2008 Jan 15; 41(1):98-107. PubMed ID: 17705444
    [Abstract] [Full Text] [Related]

  • 6. Antibody-cytotoxic agent conjugates for cancer therapy.
    Chen J, Jaracz S, Zhao X, Chen S, Ojima I.
    Expert Opin Drug Deliv; 2005 Sep 15; 2(5):873-90. PubMed ID: 16296784
    [Abstract] [Full Text] [Related]

  • 7. Antibody-drug conjugates as targeted cancer therapeutics.
    Sun Y, Yu F, Sun BW.
    Yao Xue Xue Bao; 2009 Sep 15; 44(9):943-52. PubMed ID: 20055167
    [Abstract] [Full Text] [Related]

  • 8. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
    Bodey B, Siegel SE, Kaiser HE.
    Anticancer Res; 1996 Sep 15; 16(2):661-74. PubMed ID: 8687112
    [Abstract] [Full Text] [Related]

  • 9. Antibody conjugates and therapeutic strategies.
    McCarron PA, Olwill SA, Marouf WM, Buick RJ, Walker B, Scott CJ.
    Mol Interv; 2005 Dec 15; 5(6):368-80. PubMed ID: 16394252
    [Abstract] [Full Text] [Related]

  • 10. Targeted drug delivery using immunoconjugates: principles and applications.
    Pasquetto MV, Vecchia L, Covini D, Digilio R, Scotti C.
    J Immunother; 2011 Dec 15; 34(9):611-28. PubMed ID: 21989410
    [Abstract] [Full Text] [Related]

  • 11. Drug-monoclonal antibody conjugates for cancer therapy: potentials and limitations.
    Pimm MV.
    Crit Rev Ther Drug Carrier Syst; 1988 Dec 15; 5(3):189-227. PubMed ID: 3060267
    [Abstract] [Full Text] [Related]

  • 12. Antibody-targeted drugs for the therapy of cancer.
    Pietersz GA, Krauer K.
    J Drug Target; 1994 Dec 15; 2(3):183-215. PubMed ID: 7812691
    [Abstract] [Full Text] [Related]

  • 13. Tumor delivery and in vivo processing of disulfide-linked and thioether-linked antibody-maytansinoid conjugates.
    Erickson HK, Widdison WC, Mayo MF, Whiteman K, Audette C, Wilhelm SD, Singh R.
    Bioconjug Chem; 2010 Jan 15; 21(1):84-92. PubMed ID: 19891424
    [Abstract] [Full Text] [Related]

  • 14. The next generation of antibody-drug conjugates comes of age.
    Beck A, Haeuw JF, Wurch T, Goetsch L, Bailly C, Corvaïa N.
    Discov Med; 2010 Oct 15; 10(53):329-39. PubMed ID: 21034674
    [Abstract] [Full Text] [Related]

  • 15. Antibodies in the therapy of colon cancer.
    Welt S, Ritter G.
    Semin Oncol; 1999 Dec 15; 26(6):683-90. PubMed ID: 10606261
    [Abstract] [Full Text] [Related]

  • 16. Development of a streptavidin-anti-carcinoembryonic antigen antibody, radiolabeled biotin pretargeting method for radioimmunotherapy of colorectal cancer. Reagent development.
    Karacay H, Sharkey RM, Govindan SV, McBride WJ, Goldenberg DM, Hansen HJ, Griffiths GL.
    Bioconjug Chem; 1997 Dec 15; 8(4):585-94. PubMed ID: 9258459
    [Abstract] [Full Text] [Related]

  • 17. Challenges in the development and manufacturing of antibody-drug conjugates.
    Ducry L.
    Methods Mol Biol; 2012 Dec 15; 899():489-97. PubMed ID: 22735971
    [Abstract] [Full Text] [Related]

  • 18. Development of potent monoclonal antibody auristatin conjugates for cancer therapy.
    Doronina SO, Toki BE, Torgov MY, Mendelsohn BA, Cerveny CG, Chace DF, DeBlanc RL, Gearing RP, Bovee TD, Siegall CB, Francisco JA, Wahl AF, Meyer DL, Senter PD.
    Nat Biotechnol; 2003 Jul 15; 21(7):778-84. PubMed ID: 12778055
    [Abstract] [Full Text] [Related]

  • 19. Experimental treatment of malignant gliomas with human monoclonal antibody-drug conjugates.
    Takahashi H, Adachi K, Yamaguchi F, Teramoto A.
    Anticancer Res; 1999 Jul 15; 19(5B):4151-5. PubMed ID: 10628367
    [Abstract] [Full Text] [Related]

  • 20. Monoclonal antibody therapy of cancer.
    Weiner LM.
    Semin Oncol; 1999 Oct 15; 26(5 Suppl 14):43-51. PubMed ID: 10561017
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.